$BEAM setting up as a short at $24.50—first tranche in. Watching this closely alongside $FCEL as both look like textbook short vehicles right now.
Biotech sector feels toppy. Momentum's fading, valuations stretched, and risk-off vibes building. If this leg down accelerates, could see a broader flush across speculative names.
Keeping position sizing tight and stops disciplined. This is a tactical fade, not a hero trade.
Biotech sector feels toppy. Momentum's fading, valuations stretched, and risk-off vibes building. If this leg down accelerates, could see a broader flush across speculative names.
Keeping position sizing tight and stops disciplined. This is a tactical fade, not a hero trade.